From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Infectious Diseases>
  4. Summary and Comment

HPV-16 and Oropharyngeal Cancer

HPV-16 infection was shown to be an independent risk factor for oropharyngeal squamous-cell carcinoma.

Although alcohol and tobacco use have long been recognized as major risk factors for oropharyngeal squamous-cell carcinoma, recent work has produced molecular evidence supporting a major role for human papillomavirus (HPV). Now, investigators in Baltimore have performed a case-control study to evaluate the strength of this association.

The researchers enrolled 100 patients with newly diagnosed oropharyngeal squamous-cell carcinoma from a longitudinal cohort study and 200 age- and sex-matched cancer-free controls from an outpatient otolaryngology clinical population. Most (86%) of the cancer patients were men.

Significant risk factors for cancer included history of squamous-cell carcinoma of the head or neck in a first-degree relative, poor oral hygiene, heavy tobacco or alcohol use, regular marijuana use, high lifetime number of vaginal-sex or oral-sex partners, serologic evidence of HPV type 16 infection, and presence of an oral HPV-16 infection. In an analysis restricted to patients with HPV-16–positive tumors, the association of sexual behaviors with cancer was strengthened and — contrary to findings in patients with HPV-16–negative tumors — was unaffected by alcohol and tobacco use. Multivariate analysis revealed that 55% of the oropharyngeal cancers (95% confidence interval, 45–63) were attributable to HPV-16 exposure alone. Of 60 fresh-frozen tumor specimens available from the 100 cancer patients, 35 (58%) were HPV-16–positive.

Comment: These data strongly support an independent role for HPV-16 in the pathogenesis of oropharyngeal squamous-cell carcinoma. Although the incidence of such cancers is much lower than that of cervical cancer, the present findings provide an additional reason for HPV vaccination. This potential benefit should be factored into cost-benefit analyses of HPV vaccine use for both girls and boys.

— Richard T. Ellison III, MD

Published in Journal Watch Infectious Diseases May 9, 2007

Citation(s):

D’Souza G et al. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007 May 10; 356:1944-56.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2007. Massachusetts Medical Society. All rights reserved.